RedHawk Plans to Return Component Production to U.S
Wednesday, October 2, 2019 9:00 AM
LAFAYETTE, LA / ACCESSWIRE / October 2, 2019 / RedHawk Holdings Corp. (OTC PINK:SNDD) ("RedHawk" or the "Company"), a diversified holding company engaged in sales and distribution of medical devices, branded generic pharmaceutical drugs, commercial real estate investment and leasing, point of entry full-body security systems, and specialized financial services, announced today that it plans to move production of most of the U.S.-bound electronic components for its SANDD mini™ and SANDD - HP™ needle incineration devices from China to the U.S. Production components for the re-designed SANDD Pro™ are currently expected to be manufactured in the U.S.
"During the current fourth quarter, we expect most of the electronic components of our U.S. bound SANDD mini™ and SANDD - HP™ needle incineration devices will be in production in the U.S.," said G. Darcy Klug, RedHawk's Chairman and Interim Chief Executive Officer. "Our decision to move most of the production of these electronic components from China to the U.S. is to insulate against possible U.S. tariffs. These products were both re-designed last year, which included making their electronics more manufacturing friendly. The re-design also made it more economical for U.S. manufacturers to be competitive in the bidding process. Therefore, we expect this production move will enable us to recognize certain cost savings, improve production efficiencies and shorten supply chain lead-times for these important RedHawk products."
“Rudeness is the weak man’s imitation of strength.”
